Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

87 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A prospective, multicenter, population-based study of BRAF mutational analysis for Lynch syndrome screening.
Bessa X, Ballesté B, Andreu M, Castells A, Bellosillo B, Balaguer F, Castellví-Bel S, Paya A, Jover R, Alenda C, Titó L, Martinez-Villacampa M, Vilella A, Xicola RM, Pons E, Llor X; Gastrointestinal Oncology Group of Spanish Gastroenterological Association. Bessa X, et al. Among authors: alenda c. Clin Gastroenterol Hepatol. 2008 Feb;6(2):206-14. doi: 10.1016/j.cgh.2007.10.011. Epub 2007 Dec 21. Clin Gastroenterol Hepatol. 2008. PMID: 18096441
Accuracy of revised Bethesda guidelines, microsatellite instability, and immunohistochemistry for the identification of patients with hereditary nonpolyposis colorectal cancer.
Piñol V, Castells A, Andreu M, Castellví-Bel S, Alenda C, Llor X, Xicola RM, Rodríguez-Moranta F, Payá A, Jover R, Bessa X; Gastrointestinal Oncology Group of the Spanish Gastroenterological Association. Piñol V, et al. Among authors: alenda c. JAMA. 2005 Apr 27;293(16):1986-94. doi: 10.1001/jama.293.16.1986. JAMA. 2005. PMID: 15855432
Differential features of colorectal cancers fulfilling Amsterdam criteria without involvement of the mutator pathway.
Llor X, Pons E, Xicola RM, Castells A, Alenda C, Piñol V, Andreu M, Castellví-Bel S, Payá A, Jover R, Bessa X, Girós A, Roca A, Gassull MA; Gastrointestinal Oncology Group of the Spanish Gastroenterological Association. Llor X, et al. Among authors: alenda c. Clin Cancer Res. 2005 Oct 15;11(20):7304-10. doi: 10.1158/1078-0432.CCR-05-0965. Clin Cancer Res. 2005. PMID: 16243801
Clinical performance of original and revised Bethesda guidelines for the identification of MSH2/MLH1 gene carriers in patients with newly diagnosed colorectal cancer: proposal of a new and simpler set of recommendations.
Rodríguez-Moranta F, Castells A, Andreu M, Piñol V, Castellví-Bel S, Alenda C, Llor X, Xicola RM, Jover R, Payá A, Bessa X, Balaguer F, Cubiella J, Argüello L, Morillas JD, Bujanda L; Gastrointestinal Oncology Group of the Spanish Gastroenterological Association. Rodríguez-Moranta F, et al. Among authors: alenda c. Am J Gastroenterol. 2006 May;101(5):1104-11. doi: 10.1111/j.1572-0241.2006.00522.x. Am J Gastroenterol. 2006. PMID: 16696788
Identification of MYH mutation carriers in colorectal cancer: a multicenter, case-control, population-based study.
Balaguer F, Castellví-Bel S, Castells A, Andreu M, Muñoz J, Gisbert JP, Llor X, Jover R, de Cid R, Gonzalo V, Bessa X, Xicola RM, Pons E, Alenda C, Payá A, Piqué JM; Gastrointestinal Oncology Group of the Spanish Gastroenterological Association. Balaguer F, et al. Among authors: alenda c. Clin Gastroenterol Hepatol. 2007 Mar;5(3):379-87. doi: 10.1016/j.cgh.2006.12.025. Clin Gastroenterol Hepatol. 2007. PMID: 17368238
Detection of metachronous neoplasms in colorectal cancer patients: identification of risk factors.
Ballesté B, Bessa X, Piñol V, Castellví-Bel S, Castells A, Alenda C, Paya A, Jover R, Xicola RM, Pons E, Llor X, Cordero C, Fernandez-Bañares F, de Castro L, Reñé JM, Andreu M; Gastrointestinal Oncology Group of the Spanish Gastroenterological Association. Ballesté B, et al. Among authors: alenda c. Dis Colon Rectum. 2007 Jul;50(7):971-80. doi: 10.1007/s10350-007-0237-2. Dis Colon Rectum. 2007. PMID: 17468913
Utility of p16 immunohistochemistry for the identification of Lynch syndrome.
Payá A, Alenda C, Pérez-Carbonell L, Rojas E, Soto JL, Guillén C, Castillejo A, Barberá VM, Carrato A, Castells A, Llor X, Andreu M, Koh J, Enders GH, Benlloch S, Jover R. Payá A, et al. Among authors: alenda c. Clin Cancer Res. 2009 May 1;15(9):3156-62. doi: 10.1158/1078-0432.CCR-08-3116. Epub 2009 Apr 21. Clin Cancer Res. 2009. PMID: 19383812 Free PMC article.
Comparison between universal molecular screening for Lynch syndrome and revised Bethesda guidelines in a large population-based cohort of patients with colorectal cancer.
Pérez-Carbonell L, Ruiz-Ponte C, Guarinos C, Alenda C, Payá A, Brea A, Egoavil CM, Castillejo A, Barberá VM, Bessa X, Xicola RM, Rodríguez-Soler M, Sánchez-Fortún C, Acame N, Castellví-Bel S, Piñol V, Balaguer F, Bujanda L, De-Castro ML, Llor X, Andreu M, Carracedo A, Soto JL, Castells A, Jover R. Pérez-Carbonell L, et al. Among authors: alenda c. Gut. 2012 Jun;61(6):865-72. doi: 10.1136/gutjnl-2011-300041. Epub 2011 Aug 25. Gut. 2012. PMID: 21868491
Risk of cancer in cases of suspected lynch syndrome without germline mutation.
Rodríguez-Soler M, Pérez-Carbonell L, Guarinos C, Zapater P, Castillejo A, Barberá VM, Juárez M, Bessa X, Xicola RM, Clofent J, Bujanda L, Balaguer F, Reñé JM, de-Castro L, Marín-Gabriel JC, Lanas A, Cubiella J, Nicolás-Pérez D, Brea-Fernández A, Castellví-Bel S, Alenda C, Ruiz-Ponte C, Carracedo A, Castells A, Andreu M, Llor X, Soto JL, Payá A, Jover R. Rodríguez-Soler M, et al. Among authors: alenda c. Gastroenterology. 2013 May;144(5):926-932.e1; quiz e13-4. doi: 10.1053/j.gastro.2013.01.044. Epub 2013 Jan 24. Gastroenterology. 2013. PMID: 23354017 Free article.
87 results